• You may have to login or register before you can post and view our exclusive members only forums.
    To start viewing messages, select the forum that you want to visit from the selection below.

Chinese "Devil Virus" - anyone worried?

toil5bgpse081.jpg
 
For the second time in a month, the White House on Thursday urged large businesses to move forward with coronavirus vaccine mandates for their workforces despite court challenges to the Biden administration's vaccine-or-test requirement for private companies.

"Our message to businesses right now is to move forward with measures that will make their workplaces safer and protect their workforces from COVID-19," White House press secretary Jen Psaki told reporters during a briefing. "That was our message after the first stay issued by the Fifth Circuit. That remains our message and nothing has changed."

Psaki's comments came after the Occupational Safety and Health Administration (OSHA) said it would suspend enforcement of the COVID-19 vaccine mandate for businesses after a federal appeals court reaffirmed its decision to suspend the mandate.

Psaki said Thursday that the administration remains confident that it has the authority to issue the rule, known as an emergency temporary standard, which requires businesses with more than 100 employees to require that their employees be vaccinated against COVID-19 or submit to regular testing for the virus.



Psaki also said the administration was still working off the Jan. 4 deadline it set for businesses to comply with the rule, despite the ongoing legal dispute.

"We are still heading towards the same timeline. The department of justice is vigorously defending the emergency temporary standard in court and we are confident in OSHA's authority," Psaki said.

A three-judge panel on the 5th U.S. Circuit Court of Appeals in New Orleans blocked the vaccine mandate earlier this month. The judges, all of whom were appointed by Republican presidents, described the vaccine rule as "grossly" exceeding OSHA's authority. At the time of the initial ruling, the White House urged businesses to move forward with vaccine requirements for workers.
 
That's the next big outbreak appaz. Weaponised smallpox. Ask Paddy Power for odds.

Buy SIGA stock

SIGA Technologies (NASDAQ:SIGA), a commercial-stage pharmaceutical company with its lead product targeting the human smallpox disease, is trading ~5.1% higher in the pre-market on below-average volume.

On Wednesday, the maker of FDA-approved smallpox therapy Tpoxx (tecovirimat) rose to a three-year high, continuing its winning streak for the fifth consecutive session.

The recent gains made by SIGA (SIGA) have coincided with a lab incident at a Pennsylvania vaccine research facility where an employee at the site had found multiple frozen vials labeled "smallpox."

The discovery of the deadly virus has led to an FBI and CDC investigation. "There is no indication that anyone has been exposed to the small number of frozen vials," CDC said, according to Yahoo News.

On Tuesday, SIGA (SIGA) made an announcement indicating that it was on the path for European approval of oral tecovirimat.
 
AN investigation has been launched into a spike in deaths among newborn babies in Scotland.

Official figures reveal that 21 infants died during September within 28 days of birth, causing the neonatal mortality rate to breach an upper warning threshold known as the 'control limit' for the first time in at least four years.

Control and warning limits are designed to flag up to public health teams when neonatal, stillbirth or other infant deaths are occurring at unexpectedly high or low levels which may not be due to chance.

Concerns have previously been raised about the potential impact of Covid on maternity services and maternal wellbeing, but it is the first time since the pandemic began that neonatal deaths have been so abnormally above average.

13216414.png
The neonatal mortality rate in September, at 4.9 per 1000 live births, was significantly above average

Although the rate fluctuates month to month, the figure for September - at 4.9 per 1000 live births - is on a par with levels that were last typically seen in the late 1980s.

Public Health Scotland (PHS), which is one of the bodies currently investigating the spike, said the fact that the upper control limit has been exceeded "indicates there is a higher likelihood that there are factors beyond random variation that may have contributed to the number of deaths that occurred".
 
Back
Top Bottom